HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)
Funding Opportunity PAR-18-319 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support multi-component, multi-disciplinary projects that address scientific questions relevant to AIDS prophylactic vaccine discovery research. Extensive modeling of vaccine concepts in non-human primates may be included. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 13, 2017 Category: Research Source Type: funding
Notice of Interest to Highlight Expansion of Research Topics for the HIV/AIDS Vaccine Scholars Program (K01)
Notice NOT-OD-17-116 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 28, 2017 Category: Research Source Type: funding
Pediatric Immunotherapy Translational Science Network (PI-TSN)(U54)
Funding Opportunity RFA-CA-17-050 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this FOA is to establish Centers of collaborating investigators with the goal of identifying and advancing research opportunities for translating immunotherapy concepts for children and adolescents with cancer toward clinical applications. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): Recommendation (B) t...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 26, 2017 Category: Research Source Type: funding
Pediatric Immunotherapy Translational Science Network (PI-TSN)(U01)
Funding Opportunity RFA-CA-17-051 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The overall goal of this FOA and the companion FOA, RFA-CA-17-050, is to establish a network of collaborating investigators to identify and advance research opportunities for translating immunotherapy concepts for children and adolescents with cancer toward clinical applications. Specifically, this FOA targets the following area(s) designated as a scientific priority(ies) by the Blue Ribbo...
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 26, 2017 Category: Research Source Type: funding
Request for Information (RFI): Prospective Longitudinal Cohort Studies of Influenza Infection and Vaccine Effectiveness
Notice NOT-AI-17-043 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 21, 2017 Category: Research Source Type: funding
Partnerships for Countermeasures Against Select Pathogens (R01)
Funding Opportunity RFA-AI-17-026 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit research applications for milestone-driven projects focused on preclinical development of lead candidate therapeutics, vaccines and related countermeasures against select NIAID Emerging Infectious Diseases/Pathogens. Applications must include a Product Development Strategy attachment and demonstrate substantive investment by at least one industrial participant. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 21, 2017 Category: Research Source Type: funding
Partnerships for the Development of Vaccines and Immunophrophylactics Targeting Multiple Antimicrobial-Resistant Bacteria (R01)
Funding Opportunity RFA-AI-17-017 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support milestone-driven projects focused on discovery, establishment of proof-of-concept for, and/or preclinical development of, lead candidate vaccines or immunoprophylactics that target multiple antimicrobial-resistant Gram-negative bacterial pathogens prevalent in nosocomial infections: carbapenem-resistant Enterobacteriaceae (CRE), multidrug-resistant (MDR) Acinetobacter and MDR Pseudomonas aeruginosa. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 31, 2017 Category: Research Source Type: funding
Partnerships for the Development of Vaccines and Immunoprophylactics Targeting Multiple Antimicrobial-Resistant Bacteria (R01)
Funding Opportunity RFA-AI-17-017 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support milestone-driven projects focused on discovery, establishment of proof-of-concept for, and/or preclinical development of, lead candidate vaccines or immunoprophylactics that target multiple antimicrobial-resistant Gram-negative bacterial pathogens prevalent in nosocomial infections: carbapenem-resistant Enterobacteriaceae (CRE), multidrug-resistant (MDR) Acinetobacter and MDR Pseudomonas aeruginosa. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 31, 2017 Category: Research Source Type: funding
Innovation for HIV Vaccine Discovery (R01)
Funding Opportunity PAR-17-263 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support high risk, high impact, early discovery research on vaccine approaches to prevent acquisition of or ongoing infection by HIV. In keeping with the high risk, high impact nature of this research, this FOA supports a Go/No-Go approach to funding high risk research, which is significantly different from most R01 projects. Continued funding for the full award duration is dependent upon achieving negotiated Go/No-Go criteria by the end of Year 2. (Source: NIH Funding Opportunitie...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 25, 2017 Category: Research Source Type: funding
Identification of Target Peptide Sequences for Zika IgM Diagnostic Device
Funding Opportunity ID: 292882 Opportunity Number: RFA-FD-17-002 Opportunity Title: Identification of Target Peptide Sequences for Zika IgM Diagnostic DeviceOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: AgricultureConsumer ProtectionFood and NutritionCategory Explanation: CFDA Number(s): 93.103Eligible Applicants: Others (see text field entitled "Additional Information on Eligibility" for clarification)Additional Information on Eligibility: The following organization is eligible to apply: PEPperPrint GmbHA...
Source: Grants.gov - March 31, 2017 Category: Research Tags: Agriculture Consumer Protection Food and Nutrition Source Type: funding
Pan American Health Organization (PAHO) Building Capacity and Networks to Address Emerging Infectious Diseases in the Americas (CK-1301-04SUPP2017)
Funding Opportunity ID: 292838 Opportunity Number: CDC-RFA-CK13-1301 Opportunity Title: Pan American Health Organization (PAHO) Building Capacity and Networks to Address Emerging Infectious Diseases in the Americas (CK-1301-04SUPP2017)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.099Eligible Applicants: Others (see text field entitled "Additional Information on Eligibility" for clarification)Additional Information on Eligibility: Pan American Health Organizati...
Source: Grants.gov - March 29, 2017 Category: Research Tags: Health Source Type: funding
Cooperative Ecosystem Studies Unit, Great Lakes Northern Forests CESU
Funding Opportunity ID: 292421 Opportunity Number: G17AS00048 Opportunity Title: Cooperative Ecosystem Studies Unit, Great Lakes Northern Forests CESUOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: Science and Technology and other Research and DevelopmentCategory Explanation: CFDA Number(s): 15.808Eligible Applicants: Others (see text field entitled "Additional Information on Eligibility" for clarification)Additional Information on Eligibility: This financial assistance opportunity is being issued under a Co...
Source: Grants.gov - March 13, 2017 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
National Organization to Strengthen and Support a Network of Immunization Program Managers
Opportunity ID: 291461 Opportunity Number: CDC-RFA-IP17-1703 Opportunity Title: National Organization to Strengthen and Support a Network of Immunization Program ManagersOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.185Eligible Applicants: Others (see text field entitled "Additional Information on Eligibility" for clarification)Additional Information on Eligibility: Open to any entity qualifying under 317 of the Public Health Service Act (for-profit entities d...
Source: Grants.gov - March 7, 2017 Category: Research Tags: Health Source Type: funding
Targeted Capacity Expansion-HIV Program: Substance Use Disorder Treatment for Racial/Ethnic Minority Populations at High Risk for HIV/AIDS (Short Title: TCE-HIV: High Risk Populations)
Funding Opportunity ID: 292210 Opportunity Number: TI-17-011 Opportunity Title: Targeted Capacity Expansion-HIV Program: Substance Use Disorder Treatment for Racial/Ethnic Minority Populations at High Risk for HIV/AIDS (Short Title: TCE-HIV: High Risk Populations)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.243Eligible Applicants: Others (see text field entitled "Additional Information on Eligibility" for clarification)Additional Information on Eligibility: E...
Source: Grants.gov - March 4, 2017 Category: Research Tags: Health Source Type: funding
Centers for Disease Control and Prevention Enhanced Surveillance for New Vaccine Preventable
Funding Opportunity ID: 292165 Opportunity Number: RFA-IP-16-00402CONT17 Opportunity Title: Centers for Disease Control and Prevention Enhanced Surveillance for New Vaccine PreventableOpportunity Category: ContinuationOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.185Eligible Applicants: Others (see text field entitled "Additional Information on Eligibility" for clarification)Additional Information on Eligibility: This award will be a continuation of funds intended only for grantees previously a...
Source: Grants.gov - March 3, 2017 Category: Research Tags: Health Source Type: funding
